Lanean...
Personalising medicine in inflammatory bowel disease—current and future perspectives
Up to 25% of inflammatory bowel disease (IBD) presents during childhood, often with severe and extensive disease, leading to significant morbidity including delayed growth and nutritional impairment. The classical approach to management has centred on differentiation into Crohn’s disease (CD) or ulc...
Gorde:
| Argitaratua izan da: | Transl Pediatr |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
AME Publishing Company
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6382508/ https://ncbi.nlm.nih.gov/pubmed/30881899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tp.2018.12.03 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|